results of niraparib/bevacizumab combo in platinum-sensitive recurrent ovarian cancer
Published 5 years ago • 295 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
1:42
final ananova2 survival data support niraparib plus bevacizumab in recurrent ovarian cancer
-
1:41
dr. mirza on niraparib plus bevacizumab combo in ovarian cancer
-
0:43
efficacy of niraparib on pfs in patients with recurrent ovarian cancer
-
8:03
bevacizumab in platinum-sensitive ovarian cancer
-
0:45
results for combination bevacizumab plus mirvetuximab soravtansine in ovarian cancer
-
1:50
niraparib as maintenance for platinum-sensitive ovarian cancer - results from engot-ov16/nova trial
-
3:26
niraparib monotherapy in late-line ovarian cancer
-
6:34
bevacizumab’s value in recurrent ovarian cancer
-
7:19
combination therapy with niraparib and bevacizumab for ovarian cancer
-
6:10
ago-ovar 2.29/engot-ov34: atezolizumab vs placebo bevacizumab w/ chemo recurrent ovarian cancer
-
2:55
results of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
-
3:10
overview of engot-ov16/nova of niraparib in ovarian cancer and why the results were not surprising
-
3:04
phase ii results for niraparib in heavily pretreated patients with ovarian cancer
-
9:24
results from the engot-ov16/nova trial: efficacy and safety of niraparib in ovarian cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
1:48
niraparib maintenance therapy in ovarian cancer
-
3:59
case 3: recurrent ovarian cancer, platinum-sensitive, brca wt
-
2:20
dr. matulonis discusses niraparib/pembrolizumab combo in platinum-resistant ovarian cancer